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Pityriasis rubra pilaris (PRP) is an uncommon clini-
cally heterogeneous keratinization skin disorder. PRP 
occurs equally in men and women and has a bimodal 
age distribution with typical onset during the first and 
fifth decades [1]. Due to the significant clinical diversity, 
PRP is classified into six subgroups according to age of 
onset, distribution, morphologic features, clinical course 
and human immunodeficiency virus (HIV) infection [1, 2]. 
The aetiology of the disease remains unknown but sev-
eral studies have reported its occurrence in the setting 
of viral infection, trauma, stress, associated autoimmune 
diseases, malignancies and drugs [3]. 
We present the case of a 7-year-old patient with 
type III PRP in which emotional stress appeared to be the 
most probable triggering factor. 
A 7-year-old girl was referred to our institution for 
a diagnostic evaluation of skin lesions with a 3-month 
history. The skin lesions clinically appeared as gener-
alised erythroderma. Locally, physical examination re-
vealed diffuse pityriasiform scale of the scalp, confluent 
areas of erythema on the trunk (Figure 1 C) and follicu-
lar hyperkeratotic papules within erythematosquamous 
plaques with an orange hue distributed on the legs. 
Patches of normal skin were evident within those sheets 
of erythema (Figure 1 A). Waxy palmoplantar keratoder-
ma with fissures was observed (Figure 1 B). Skin burn-
ing sensation and itching accompanied skin lesions. The 
patient’s past medical history was notable only for mild 
xerosis cutis. A review of systems was non-contributory. 
Family history of psoriasis and atopic diseases was nega-
tive. There were no similar previous episodes or recent 
exposure to drugs or infections. Four months before 
hospitalisation the patient began primary school. Her 
mother noted that in that time the patient developed 
anxiety, aggressiveness and social isolation due to rejec-
tion by friends in her class. She tended to refrain from 
social activities in the presence of peers. The first skin 
lesions in the form of scaly erythematous patches devel-
oped initially over the elbows and knees 4 weeks after 
the First Day of Class. Despite initial therapy with hy-
droxyzine and emollients prescribed by her primary care 
physician, the plaques spread throughout the patient’s 
face, scalp, torso and limbs. Her hands and feet devel-
oped an orange-red appearance with desquamation. She 
was referred to the Paediatric Dermatology Department 
where she was clinically diagnosed with generalised pus-
tular psoriasis. Topical treatment with anthralin cream 
resulted in rapid deterioration of skin findings. At admis-
sion basic laboratory and microbiological examinations 
were performed. Laboratory investigations revealed mild 
eosinophilia (1000/µl) and a high serum immunoglobulin 
E level (1100 IU/ml). Lesional punch biopsy of affected 
skin documented alternating orthokeratosis and para-
keratosis, an absence of Munro microabscesses, a low-
grade superficial perivascular infiltration of lymphocytes 
and plugging of follicular infundibula by cornified cells 
(Figure 2). The image corresponded to the clinical diagno-
sis of classic juvenile type III PRP. The patient was treated 
with oral acitretin 10 mg daily (approximately 0.3 mg/kg), 
moisturizing creams, topical 10% urea ointment (hands 
and feet) and topical 5% salicylic acid ointment (scalp). 
The duration of acitretin therapy was 3 months. Within 
2 months, the patient improved remarkably. The papules 
and plaques resolved completely with residual postin-
flammatory hyperpigmentation (Figure 3). The patient 
did not suffer from any adverse reactions to acitretin 
other than xerosis cutis.
The incidence of PRP in children is not precisely 
known, though in one study the disease has been es-
timated to be present in approximately 1/500 patients 
hospitalized in the Paediatric Unit with a skin disorder 
[4]. Type III (classical juvenile) represents approximately 
10% of PRP with a median age of onset of 5–10 years 
[3]. Erythroderma can be one of the most remarkable 
clinical findings. In one retrospective series, 24% of chil-
dren presenting type III PRP had erythroderma [5]. Other 
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clinical features consist of hyperkeratotic follicular pap-
ules and plaques that coalesce with islands of sparing 
and orange-hued palmoplantar keratoderma. Maximum 
spread is typically within 3 months. Mucosal involve-
ment is uncommon [6]. It is considered to be prognos-
tically favourable with a spontaneous clearance within 
1–2 years [3]. The recurrence rate is about 17% [5]. PRP is 
diagnosed clinically with skin biopsy findings being sup-
portive but not pathognomic. Characteristic histological 
features consist of psoriasiform hyperplasia, alternat-
ing orthokeratosis and parakeratosis (checkerboard 
pattern), follicular plugging and scanty superficial peri-
vascular infiltrate within the dermis. Unlike psoriasis, 
in PRP neutrophils are not present in the epidermis or 
C
Figure 1 A, B – Hyperkeratotic papules, patches of normal skin and erythematosquamous plaques with an orange hue 
distributed on the legs. C – Waxy palmoplantar keratoderma with fissures. D – Confluent areas of erythema covered with 
diffuse pityriasiform scale on the trunk
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stratum corneum [7, 8]. A detailed family and personal 
history should be obtained to help rule out common 
differential diagnosis such as psoriasis, atypical kerato-
sis pilaris, phrynoderma, atopic dermatitis, ichthyoses, 
seborrheic dermatitis and palmoplantar keratoderma. 
There are no standard recommended treatment algo-
rithms for PRP in paediatric patients. Based on few 
long-term studies on the treatment and prognosis, sys-
temic retinoids are considered the first-line therapy [9, 
10]. Treatment with acitretin at 0.3 mg/kg was highly 
effective in our patient. Within the last decade, several 
case reports have noted efficacy of biologic therapies 
initially approved to treat plaque psoriasis such as TNF 
inhibition [11, 12]. 
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In conclusion, we herein present an unusual case 
report showing that in paediatric population emotional 
stress can be the isolated trigger for the occurrence of 
PRP. Further investigations are needed to identify the 
pathomechanism of antecedent psychological stress and 
onset of PRP.
Conflict of interest
The authors declare no conflict of interest.
Figure 2. The biopsy shows alternating orthokeratosis and 
parakeratosis in a checkerboard pattern and plugging of 
follicular infundibula by cornified cells (H + E, magnifica-
tion 100×)
Figure 3. After 2 months the papules and plaques resolved 
completely with residual postinflammatory hyperpigmenta-
tion and xerosis cutis
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